Skip to main content

Genetic and Molecular Basis of Neurodevelopmental Disorders

Neuroscience

Image of Gaia Novarino

Gaia Novarino

Professor


1 Career

  • Since 2024 Executive Vice President, Institute of Science and Technology Austria (ISTA)
  • Since 2021 Vice President for Science Education, Institute of Science and Technology Austria (ISTA)
  • Since 2019 Professor, Institute of Science and Technology Austria (ISTA)
  • 2014 – 2019 Assistant Professor, Institute of Science and Technology Austria (ISTA)
  • 2010 – 2013   Postdoctoral Fellow, Neuroscience Department, School of Medicine, University of California San Diego (UCSD), USA
  • 2006 – 2010 Postdoctoral Fellow, Max Delbruck Center for Molecular Medicine, Berlin, Germany

1.1 Selected Distinctions

  • 2026 Elected chair of the program committee FENS forum 2028
  • 2025 Elected member of the European Molecular Biology Organization (EMBO)
  • 2016 – 2021 FENS-Kavli Network of Excellence Scholar 
  • 2016   Boehringer Ingelheim FENS Research Award

1.2 Selected Grants

  • 2023 – 2028 Emerging Fields, Brain Resilience, FWF.
  • 2022 – 2027 ERC consolidator grant, Toward an understanding of the brain interstitial system and the extracellular proteome in health and autism spectrum disorders.
  • 2020 – 2025 Simons foundation for Autism Research (SFARI), research award.

1.3 Tech Transfer (Patents, Spin-Offs)

  • Co-founder and Scientific Advisor of Solgate
  • Co-founder and Scientific Advisor of Neurolentech
  • Shareholder and Scientific Advisor Cellgate

1.4 Selected Publications

  1. Deliu E, Arecco N, Morandell J, Dotter CP, Contreras X, Girardot C, Kaesper E, Kozlova A, Kishi K, Chiaradia I, Noh K, Novarino G. Haploinsufficiency of intellectual disability-gene SETD5 disturbs developmental gene expression and cognition. Nature Neuroscience, 2018 Dec;21(12):1717-1727. DOI: 10.1038/s41593-018-0266-2.
  2. Morandell J, Schwarz LA, Basilico B, Tasciyan A, Nicolas A, Sommer C, Kreuzinger C, Dotter CP, Knaus LS, Dobler Z, Cacci E, Danzl JG, Novarino G. Cul3 regulates cytoskeleton protein homeostasis and cell migration during a critical window of brain development. Nature Communications, 2021 May 24;12(1):3058. DOI: 10.1038/s41467-021-23123-x.
  3. Villa CE, Cheroni C, Dotter CP, López-Tóbon A, Oliveira B, Sacco R, Yahya AC, Morandell J, Gabriele M, Tavakoli RM, Lyudchik J, Sommer C, Gabitto M, Danzl GJ, Testa G and Novarino G. CHD8 haploinsufficiency alters the developmental trajectories of human excitatory and inhibitory neurons linking autism phenotypes with transient cellular defects. Cell Rep. 2022 Apr 5;39(1):110615. DOI: 10.1016/j.celrep.2022.110615.
  4. Knaus SL, Basilico B, Malzl D, Gerykova Bujalkova M, Smogavec M, Schwarz AL, Gorkiewicz S, Amberg N, Pauler F, Knittl-Frank C, Tassinari M, Maulide N,Rülicke T, Menche J, Hippenmeyer S, Novarino G. Large neutral amino acid levels tune perinatal neuronal excitability and survival. Cell, 2023 April 27;186(9):1950-1967.e25. DOI: 10.1016/j.cell.2023.02.037. 
  5. Schwarz LA, Dotter CP, Isaev S, Lisi M, Malzl D, Büschl C, Ladstätter S, Oliveira B, Barel M, Basilico B, Chintaluri C, Gorkiewicz S, Goudarzi M, Belinova T, Reichl S, Sendžikaitė G, Arcot Jayaram S, Koppensteiner P, Sommer C, Vogels TP, Menche J, Adameyko I, Kharchenko PV, Bock C, Novarino G. Cortical development dynamics across autism spectrum disorder mouse models. Nature, 2026 June 17; 656, 159–172. DOI: 10.1038/s41586-026-10679-1.

2 Group Members

  • Francesca Barbieri, PhD Student since 2021
  • Matteo Barel, PhD Student since 2022
  • Sarah Gorkiewicz, PhD Student since 2020
  • Emily Haimerl, PhD Student since 2023
  • Martina Rispoli, PhD Student since 2023
  • Simon Schnabl, PhD Student since 2022
  • Sara D’Angelo, Postdoc since 2024
  • Romina Antonela Gisonno, Postdoc since 2021
  • Michela Lisi, Postdoc since 2025
  • Franco Luis Lombino, Postdoc since 2022
  • Domenico Marano, Postdoc since 2022
  • Vittoria Mariano, Postdoc since 2023
  • Giada Pacinelli, Postdoc since 2025
  • Lena Schwarz, Postdoc since 2018
  • Farnaz Freeman, Research Technician since 2018
  • Viktor Voronin, Research Technician since 2021

3 Research

Millions of people around the world live with neurodevelopmental disorders, including epilepsy, intellectual disability and autism spectrum disorders (ASD), conditions that shape every aspect of daily life and for which effective treatments remain out of reach.

These disorders stem from mutations across a large number of genes, most of which we still understand poorly when it comes to how they function in the brain. By combining approaches from molecular biology all the way to behavioral analysis, the Novarino group studies these genetic mutations and their relevance to brain development and function. Importantly, our research goes beyond identifying genes: it explores their function at the molecular, cellular, and systems levels. This integrated approach allows our group to link genetic mutations to changes in neural circuits that underlie disorder-linked traits. Through this work, the Novarino group aims to define critical biological processes that are essential for normal brain development and function.

Finally, a central goal of the Novarino Group is to use these insights to guide the development of effective pharmacological therapies. At the same time, studying these genetic mechanisms significantly deepens our understanding of the human brain. By revealing how specific molecular pathways shape neural circuits and behavior, autism research becomes a powerful tool not only for improving treatment, but also for uncovering the fundamental principles governing brain functions.


3.1 Current Scientific Projects/Directions

  • Molecular mechanisms underlying autism spectrum disorders
  • Chromatin remodeling in intellectual disability
  • Studying convergences and divergences across genetically defined autism disorders
  • Metabolic pathways in neurodevelopmental disorders
  • Sex-related differences in neurodevelopmental disorders

3.2 Research in Focus

Autism spectrum disorders (ASD) are a heterogeneous group of disorders rooted in genetic bases. Although genetic studies have identified many ASD-risk genes over the past few years, it remains essentially unknown whether mutations in different genes result in similar molecular and cellular states within the brain. Over the past years, we have generated a large cohort of ASD mouse models carrying mutations in top, high-risk ASD genes. The cohort includes 11 mouse lines and span chromatin remodelers, ubiquitin-related genes, metabolically relevant genes, and synaptic proteins. Employing these validated mouse models, we performed simultaneous single nucleus RNA and ATAC sequencing across brain regions, developmental stages, and sexes, totaling over 300 samples. We achieved this by pioneering an approach that allowed us to sequence RNA and DNA from the same nucleus on a large scale. With this unique dataset, we could address precise questions regarding convergence and divergences across different ASD models, time windows affected, and sex differences. (Nature, 2026, DOI: 10.1038/s41586-026-10679-1)



theme sidebar-arrow-up
Back to Top